Genomics Market In US 2026-2030

Description

The genomics market in us is forecasted to grow by USD 9246.2 mn during 2025-2030, accelerating at a CAGR of 12.9% during the forecast period. The report on the genomics market in us provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by technological innovations in next generation sequencing and bioinformatics integration, increasing demand for creating and upgrading genome databases, integration of AI and ML in genomic data analysis.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year	2026
End Year	2030
Series Year	2026-2030
Growth Momentum	Accelerate
YOY 2026	11.7%
CAGR	12.9%
Incremental Value	$9246.2 mn

Technavio's genomics market in us is segmented as below:

By Application

Diagnostics
Drug discovery
Others

By End-User

Hospitals and clinics
Academics and research institutes
Pharmaceuticals and biotechnology companies
Others

By Solution

Products
Services

Geography

North America
- US

This study identifies the acceleration of precision medicine and targeted oncology clinical integration as one of the prime reasons driving the genomics market in us growth during the next few years. Also, advances in sequencing technologies and growing applications of genomics in oncology will lead to sizable demand in the market.

The report on the genomics market in us covers the following areas:

Genomics market in us sizing
Genomics market in us forecast
Genomics market in us industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading genomics market in us vendors that include Agilent Technologies Inc., Bio Rad Laboratories Inc., Caris Life Sciences, CENTOGENE NV, Danaher Corp., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Illumina Inc., LetsGetChecked, Myriad Genetics Inc., Natera Inc., Oxford Nanopore Technologies, Pacific Biosciences Inc., Personalis Inc., QIAGEN N.V., Revvity Inc., Thermo Fisher Scientific Inc., Twist Bioscience Corp.. Also, the genomics market in us analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR76485

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Country Market Characteristics
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Solution
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030

3 Market Landscape

3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Chart on Market characteristics analysis
3.3 Value chain analysis
- Chart on Value chain analysis

4 Market Sizing

4.1 Market definition
- Data Table on Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2025
4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

5.1 Genomics Market in US 2020 - 2024
- Historic Market Size - Data Table on Genomics Market in US 2020 - 2024 ($ million)
5.2 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
5.3 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
5.4 Solution segment analysis 2020 - 2024
- Historic Market Size - Solution Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

6.1 The AI impact on Genomics Market in US

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
7.7 Market condition
- Chart on Market condition - Five forces 2025 and 2030

8 Market Segmentation by Application

8.1 Market segments
- Chart on Application - Market share 2025-2030 (%)
- Data Table on Application - Market share 2025-2030 (%)
8.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
8.3 Diagnostics - Market size and forecast 2025-2030
- Chart on Diagnostics - Market size and forecast 2025-2030 ($ million)
- Data Table on Diagnostics - Market size and forecast 2025-2030 ($ million)
- Chart on Diagnostics - Year-over-year growth 2025-2030 (%)
- Data Table on Diagnostics - Year-over-year growth 2025-2030 (%)
8.4 Drug discovery - Market size and forecast 2025-2030
- Chart on Drug discovery - Market size and forecast 2025-2030 ($ million)
- Data Table on Drug discovery - Market size and forecast 2025-2030 ($ million)
- Chart on Drug discovery - Year-over-year growth 2025-2030 (%)
- Data Table on Drug discovery - Year-over-year growth 2025-2030 (%)
8.5 Others - Market size and forecast 2025-2030
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
8.6 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)

9 Market Segmentation by End-user

9.1 Market segments
- Chart on End-user - Market share 2025-2030 (%)
- Data Table on End-user - Market share 2025-2030 (%)
9.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
9.3 Hospitals and clinics - Market size and forecast 2025-2030
- Chart on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
- Data Table on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
- Chart on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
- Data Table on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
9.4 Academics and research institutes - Market size and forecast 2025-2030
- Chart on Academics and research institutes - Market size and forecast 2025-2030 ($ million)
- Data Table on Academics and research institutes - Market size and forecast 2025-2030 ($ million)
- Chart on Academics and research institutes - Year-over-year growth 2025-2030 (%)
- Data Table on Academics and research institutes - Year-over-year growth 2025-2030 (%)
9.5 Pharmaceuticals and biotechnology companies - Market size and forecast 2025-2030
- Chart on Pharmaceuticals and biotechnology companies - Market size and forecast 2025-2030 ($ million)
- Data Table on Pharmaceuticals and biotechnology companies - Market size and forecast 2025-2030 ($ million)
- Chart on Pharmaceuticals and biotechnology companies - Year-over-year growth 2025-2030 (%)
- Data Table on Pharmaceuticals and biotechnology companies - Year-over-year growth 2025-2030 (%)
9.6 Others - Market size and forecast 2025-2030
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
9.7 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)

10 Market Segmentation by Solution

10.1 Market segments
- Chart on Solution - Market share 2025-2030 (%)
- Data Table on Solution - Market share 2025-2030 (%)
10.2 Comparison by Solution
- Chart on Comparison by Solution
- Data Table on Comparison by Solution
10.3 Products - Market size and forecast 2025-2030
- Chart on Products - Market size and forecast 2025-2030 ($ million)
- Data Table on Products - Market size and forecast 2025-2030 ($ million)
- Chart on Products - Year-over-year growth 2025-2030 (%)
- Data Table on Products - Year-over-year growth 2025-2030 (%)
10.4 Services - Market size and forecast 2025-2030
- Chart on Services - Market size and forecast 2025-2030 ($ million)
- Data Table on Services - Market size and forecast 2025-2030 ($ million)
- Chart on Services - Year-over-year growth 2025-2030 (%)
- Data Table on Services - Year-over-year growth 2025-2030 (%)
10.5 Market opportunity by Solution
- Market opportunity by Solution ($ million)
- Data Table on Market opportunity by Solution ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Drivers, Challenges, and Opportunity

12.1 Market drivers
- Technological innovations in next generation sequencing and bioinformatics integration
- Increasing demand for creating and upgrading genome databases
- Integration of AI and ML in genomic data analysis
12.2 Market challenges
- Data security and regulatory compliance issues
- Reimbursement hurdles and economic disparities
- Clinical integration and workforce shortages
12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
12.4 Market opportunities
- Acceleration of precision medicine and targeted oncology clinical integration
- Advances in sequencing technologies
- Growing applications of genomics in oncology

13 Competitive Landscape

13.1 Overview
13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
13.3 Landscape disruption
- Overview on factors of disruption
13.4 Industry risks
- Impact of key risks on business

14 Competitive Analysis

14.1 Companies profiled
- Companies covered
14.2 Company ranking index
- Company ranking index
14.3 Market positioning of companies
- Matrix on companies position and classification
14.4 Agilent Technologies Inc.
- Agilent Technologies Inc. - Overview
- Agilent Technologies Inc. - Business segments
- Agilent Technologies Inc. - Key news
- Agilent Technologies Inc. - Key offerings
- Agilent Technologies Inc. - Segment focus
- SWOT
14.5 Bio Rad Laboratories Inc.
- Bio Rad Laboratories Inc. - Overview
- Bio Rad Laboratories Inc. - Business segments
- Bio Rad Laboratories Inc. - Key news
- Bio Rad Laboratories Inc. - Key offerings
- Bio Rad Laboratories Inc. - Segment focus
- SWOT
14.6 Danaher Corp.
- Danaher Corp. - Overview
- Danaher Corp. - Business segments
- Danaher Corp. - Key news
- Danaher Corp. - Key offerings
- Danaher Corp. - Segment focus
- SWOT
14.7 Eurofins Scientific SE
- Eurofins Scientific SE - Overview
- Eurofins Scientific SE - Business segments
- Eurofins Scientific SE - Key offerings
- Eurofins Scientific SE - Segment focus
- SWOT
14.8 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
14.9 Illumina Inc.
- Illumina Inc. - Overview
- Illumina Inc. - Business segments
- Illumina Inc. - Key news
- Illumina Inc. - Key offerings
- Illumina Inc. - Segment focus
- SWOT
14.10 LetsGetChecked
- LetsGetChecked - Overview
- LetsGetChecked - Product / Service
- LetsGetChecked - Key offerings
- SWOT
14.11 Myriad Genetics Inc.
- Myriad Genetics Inc. - Overview
- Myriad Genetics Inc. - Product / Service
- Myriad Genetics Inc. - Key news
- Myriad Genetics Inc. - Key offerings
- SWOT
14.12 Natera Inc.
- Natera Inc. - Overview
- Natera Inc. - Product / Service
- Natera Inc. - Key news
- Natera Inc. - Key offerings
- SWOT
14.13 Oxford Nanopore Technologies
- Oxford Nanopore Technologies - Overview
- Oxford Nanopore Technologies - Product / Service
- Oxford Nanopore Technologies - Key offerings
- SWOT
14.14 Pacific Biosciences Inc.
- Pacific Biosciences Inc. - Overview
- Pacific Biosciences Inc. - Product / Service
- Pacific Biosciences Inc. - Key news
- Pacific Biosciences Inc. - Key offerings
- SWOT
14.15 QIAGEN N.V.
- QIAGEN N.V. - Overview
- QIAGEN N.V. - Product / Service
- QIAGEN N.V. - Key news
- QIAGEN N.V. - Key offerings
- SWOT
14.16 Revvity Inc.
- Revvity Inc. - Overview
- Revvity Inc. - Business segments
- Revvity Inc. - Key offerings
- Revvity Inc. - Segment focus
- SWOT
14.17 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
14.18 Twist Bioscience Corp.
- Twist Bioscience Corp. - Overview
- Twist Bioscience Corp. - Product / Service
- Twist Bioscience Corp. - Key offerings
- SWOT

15 Appendix

15.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
15.3 Currency conversion rates for US$
- Currency conversion rates for US$
15.4 Research methodology
- Research methodology
15.5 Data procurement
- Information sources
15.6 Data validation
- Data validation
15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
15.8 Data synthesis
- Data synthesis
15.9 360 degree market analysis
- 360 degree market analysis
15.10 List of abbreviations
- List of abbreviations